Skip to main content
OpenTrials
Completed

NCT Number: NCT02501044

Oxygen Desaturation During Hemodialysis

Hemodialysis patients may experience drops in blood oxygen saturation during the hemodialysis treatment, which may lead to hypoxia in the tissues.

The investigators hypothesize that:

1. The cumulative number, severity, or other characteristics of such deoxygenation episodes may be a predictor of adverse outcomes in hemodialysis patients. 2. There may be demographic, anthropometric, clinical, treatment prescription, lab analytical, and other parameters that correlate with the number and severity of deoxygenation episodes and, therefore, may be used for risk stratification. Further, some of these parameters may be modifiable.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hemodialysis patient

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Cumulative number of deoxygenation episodes

    Time frame: Up to 36 months

    Crit-Line III monitor recordings (which contain oxygen saturation data) will be extracted from the RRI database and the cumulative number of deoxygenation episodes will be analyzed.

Sponsors and collaborators

Lead sponsor

Renal Research Institute

Other

Registry information

Official study title

Oxygen Desaturation During Hemodialysis: Clinical Correlates and Association With Adverse Outcomes

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Jul 17, 2015
Registry last updated
Jul 17, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.